IT1397446B1 - Compositions comprising amino acids for prevention and/or treatment of renal disorders. - Google Patents

Compositions comprising amino acids for prevention and/or treatment of renal disorders.

Info

Publication number
IT1397446B1
IT1397446B1 ITTO2010A000012A ITTO20100012A IT1397446B1 IT 1397446 B1 IT1397446 B1 IT 1397446B1 IT TO2010A000012 A ITTO2010A000012 A IT TO2010A000012A IT TO20100012 A ITTO20100012 A IT TO20100012A IT 1397446 B1 IT1397446 B1 IT 1397446B1
Authority
IT
Italy
Prior art keywords
prevention
compositions
treatment
amino acids
renal disorders
Prior art date
Application number
ITTO2010A000012A
Other languages
English (en)
Inventor
Franco Conti
Francesco Saverio Dioguardi
Original Assignee
Professional Dietetics Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics Srl filed Critical Professional Dietetics Srl
Priority to ITTO2010A000012A priority Critical patent/IT1397446B1/it
Priority to EP11702711A priority patent/EP2523662A1/en
Priority to PCT/IB2011/050132 priority patent/WO2011086507A1/en
Priority to US13/521,937 priority patent/US20130237577A1/en
Priority to CA2786764A priority patent/CA2786764C/en
Publication of ITTO20100012A1 publication Critical patent/ITTO20100012A1/it
Application granted granted Critical
Publication of IT1397446B1 publication Critical patent/IT1397446B1/it
Priority to US14/225,556 priority patent/US9421190B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
ITTO2010A000012A 2010-01-12 2010-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders. IT1397446B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITTO2010A000012A IT1397446B1 (it) 2010-01-12 2010-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders.
EP11702711A EP2523662A1 (en) 2010-01-12 2011-01-12 "compositions comprising amino acids for prevention and/or treatment of renal disorders"
PCT/IB2011/050132 WO2011086507A1 (en) 2010-01-12 2011-01-12 "compositions comprising amino acids for prevention and/or treatment of renal disorders"
US13/521,937 US20130237577A1 (en) 2010-01-12 2011-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders
CA2786764A CA2786764C (en) 2010-01-12 2011-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders
US14/225,556 US9421190B2 (en) 2010-01-12 2014-03-26 Compositions comprising amino acids for prevention and/or treatment of renal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO2010A000012A IT1397446B1 (it) 2010-01-12 2010-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders.

Publications (2)

Publication Number Publication Date
ITTO20100012A1 ITTO20100012A1 (it) 2011-07-13
IT1397446B1 true IT1397446B1 (it) 2013-01-10

Family

ID=42537487

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO2010A000012A IT1397446B1 (it) 2010-01-12 2010-01-12 Compositions comprising amino acids for prevention and/or treatment of renal disorders.

Country Status (5)

Country Link
US (2) US20130237577A1 (it)
EP (1) EP2523662A1 (it)
CA (1) CA2786764C (it)
IT (1) IT1397446B1 (it)
WO (1) WO2011086507A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653720B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Prevention of protein glycation using lysine/zinc supplements
US10610544B2 (en) 2017-11-03 2020-04-07 Lysulin, Inc. Insulin resistance and beta cell function using lysine-based supplements
US11255838B2 (en) 2017-11-03 2022-02-22 Lysulin, Inc. Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
US10466256B2 (en) * 2017-11-03 2019-11-05 Lysulin, Inc. Inhibiting chronic blood and nephrological disorders using lysine-based supplements
IT202000021664A1 (it) * 2020-09-14 2022-03-14 Iaf Network S P A Formulazione amminoacidica bilanciata
CN113304243B (zh) * 2021-04-23 2023-07-04 南方医科大学南方医院 一种人发提取生物活性肽在制备改善慢性肾脏病蛋白代谢治疗药物中的应用及药物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444621A (en) * 1973-04-30 1976-08-04 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
IT1289754B1 (it) * 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi
IT1320783B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
US20030187049A1 (en) * 2000-07-04 2003-10-02 Dioguardi Francesco Saverio Compositions based on aminoacids, suitable for improving muscle performance
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20010804A1 (it) * 2001-08-08 2003-02-08 Professional Dietetics Srl Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
ITTO20030789A1 (it) * 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
JP2008247896A (ja) * 2007-03-07 2008-10-16 Shizuokaken Koritsu Daigaku Hojin 透析患者用経口アミノ酸組成物
ITTO20080443A1 (it) * 2008-06-06 2009-12-07 Professional Dietetics Srl Composizioni comprendenti amminoacidi, con attivita' pro-angiogenica

Also Published As

Publication number Publication date
US20140206736A1 (en) 2014-07-24
WO2011086507A8 (en) 2011-09-29
ITTO20100012A1 (it) 2011-07-13
CA2786764C (en) 2016-11-15
EP2523662A1 (en) 2012-11-21
CA2786764A1 (en) 2011-07-21
WO2011086507A1 (en) 2011-07-21
US9421190B2 (en) 2016-08-23
US20130237577A1 (en) 2013-09-12

Similar Documents

Publication Publication Date Title
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
FI20095836A (fi) Probioottinen valmiste koirien maha- ja suolistohäiriöiden ennaltaehkäisyyn tai hoitoon
BR112013016535A2 (pt) extratos vegetais para o tratamento e prevenção de infecções
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BR112012018947A2 (pt) composição farmacêutica para tratamento e\ou prevenção do cancêr
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
BR112013012485A2 (pt) método de tratamento com inibidor braf
EP2699256A4 (en) COMPOSITIONS AND METHOD FOR TREATING NEUROMYELITIS OPTICA
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
SMT201400165B (it) Composizioni e metodi per il trattamento di sclerosi multipla
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
BR112014004416A2 (pt) composições e métodos para o tratamento de doenças neurodegenerativas
IL253853A0 (en) Methods and preparations for the treatment or prevention of symptoms of hormonal changes
IT1397446B1 (it) Compositions comprising amino acids for prevention and/or treatment of renal disorders.
BR112013003275A2 (pt) composição de tratamento oral
BRPI0914139A2 (pt) composições pediátricas para o tratamento de esclerose múltipla
BRPI0912679A2 (pt) composição farmacêutica para o tratamento de fibromialgia
HU0900231D0 (en) Compositions for the treatment of allergic disorders